Get Started

GOSS

NASD Gossamer Bio, Inc.
Oct 23, 2026 · 7:51 PM ET LAST TRADE Market Closed

$9.79 ↑ +0.18 (+1.93%) Trading Up from the previous close of $9.61, and at the day’s high of $9.77

YTD change
-96.05%
vs 20-day SMA
-2.68%
vs 200-day SMA
-79.14%

Price ranges

Previous day
$9.34 $9.97
open $9.73 close $9.46
-$0.27 (-2.77%)
Today
$9.00 $9.77
open $9.40 now $9.79
+$0.39 (+4.15%)
Past week
$8.29 $10.39
from $8.89 now $9.79
+$0.90 (+10.12%)
Past month
$8.29 $12.46
from $10.93 now $9.79
-$1.14 (-10.43%)
This year
$0.11 $248.00
from $248.00 now $9.79
-$238.21 (-96.05%)

Price & Performance

+9.09 (+2432.12%) / 6M

$-0.8083$3.76$8.32$12.88Apr 23Jul 24Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 99.5% away from all-time highs of $2,171.98
  • GOSS is down 96% since the beginning of the year
  • GOSS is down 94% over the past 12 months
  • GOSS is down 10% over the past 1 month
  • 20% of all GOSS investors are betting against GOSS

GOSS reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +352.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-6.4
Earnings momentum -68.8% Quarterly EPS growth
Quarterly change -68.8%

Valuation

P/E ratio N/A
Enterprise value $21.9M
Beta 3.30

Balance sheet & scale

IncomeN/A
Revenue$53.3M
Cash$57.0M
Debt$40.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $63.9M

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 26, 2015 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $447.28 +2.04%
MRNA Moderna, Inc. $202.63 -17.57%
RVMD Revolution Medicines, Inc. $187.69 -3.39%
ROIV Roivant Sciences Ltd. $37.45 +1.77%
BNTX BioNTech SE Sponsored ADR $89.67 -1.77%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.